Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Saved in:
| Title: | Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. |
|---|---|
| Authors: | Seternes OM; Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway. olems@fagmed.uit.no, Mikalsen T, Johansen B, Michaelsen E, Armstrong CG, Morrice NA, Turgeon B, Meloche S, Moens U, Keyse SM |
| Source: | The EMBO journal [EMBO J] 2004 Dec 08; Vol. 23 (24), pp. 4780-91. Date of Electronic Publication: 2004 Dec 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0261-4189 (Print) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
